The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-3-(2,3-difluorobenzylsulfonyl)-N-(1-cyanocyclopropyl)-2-((S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethylamino)propanamide ID: ALA400750
PubChem CID: 23648286
Max Phase: Preclinical
Molecular Formula: C22H19F6N3O3S
Molecular Weight: 519.47
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: N#CC1(NC(=O)[C@H](CS(=O)(=O)Cc2cccc(F)c2F)N[C@@H](c2ccc(F)cc2)C(F)(F)F)CC1
Standard InChI: InChI=1S/C22H19F6N3O3S/c23-15-6-4-13(5-7-15)19(22(26,27)28)30-17(20(32)31-21(12-29)8-9-21)11-35(33,34)10-14-2-1-3-16(24)18(14)25/h1-7,17,19,30H,8-11H2,(H,31,32)/t17-,19-/m0/s1
Standard InChI Key: SQIHYRIDUCIHLT-HKUYNNGSSA-N
Molfile:
RDKit 2D
35 37 0 0 1 0 0 0 0 0999 V2000
9.5881 -1.9447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0618 -1.3112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7785 -2.0860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3443 -1.2960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3356 -2.1207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0502 -2.5414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7695 -2.1309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7749 -1.3031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0607 -0.8864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4868 -0.8905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2044 -1.3040 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9167 -0.8936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6335 -1.3048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3484 -0.8953 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6335 -2.1364 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.5937 -0.6836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1254 -0.0535 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9167 -0.0697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4868 -0.0670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4868 0.7582 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.3170 -0.0670 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.6665 -0.0670 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.6341 0.3418 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.3502 0.7545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0506 -0.3766 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2253 1.0555 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.3509 1.5798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0660 1.9857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0670 2.8102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3522 3.2243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6347 2.8078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6372 1.9847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7789 1.5700 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9.7823 3.2219 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.6170 -2.5264 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9 4 1 0
8 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
13 15 2 0
14 2 1 0
2 16 1 0
16 17 3 0
12 18 1 1
10 19 1 1
19 20 1 0
19 21 1 0
19 22 1 0
18 23 1 0
23 24 1 0
23 25 2 0
23 26 2 0
24 27 1 0
2 1 1 0
27 28 2 0
3 2 1 0
28 29 1 0
1 3 1 0
29 30 2 0
4 5 2 0
30 31 1 0
5 6 1 0
31 32 2 0
32 27 1 0
6 7 2 0
28 33 1 0
7 8 1 0
29 34 1 0
8 9 2 0
5 35 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 519.47Molecular Weight (Monoisotopic): 519.1051AlogP: 3.45#Rotatable Bonds: 9Polar Surface Area: 99.06Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.63CX Basic pKa: 1.74CX LogP: 2.87CX LogD: 2.86Aromatic Rings: 2Heavy Atoms: 35QED Weighted: 0.49Np Likeness Score: -1.40
References 1. Gauthier JY, Black WC, Courchesne I, Cromlish W, Desmarais S, Houle R, Lamontagne S, Li CS, Massé F, McKay DJ, Ouellet M, Robichaud J, Truchon JF, Truong VL, Wang Q, Percival MD.. (2007) The identification of potent, selective, and bioavailable cathepsin S inhibitors., 17 (17): [PMID:17590332 ] [10.1016/j.bmcl.2007.06.023 ]